Ladoire et al. analyzed the changes in subclassified TILs, focusing upon CD8 and FOXP3 status in a breast cancer series including 19 cases of ER-negative disease, and reported that the ratio of CD8/FOXP3 following chemotherapy may correlate with improved prognosis [26]. This evidence concerns the gene CD8A and breast carcinoma.